Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease

被引:5
作者
Sweeney, Jacob R. [1 ]
Crawford, Carl, V [2 ]
Yantiss, Rhonda K. [3 ]
机构
[1] Cleveland Clin, Dept Pathol & Lab Med, Cleveland, OH 44106 USA
[2] Weill Cornell Med, Div Gastroenterol & Hepatol, New York, NY USA
[3] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA
关键词
infection; Crohn disease; ulcerative colitis; pseudomembranous colitis; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; INFECTION; SOCIETY; UPDATE; COLECTOMY; DIARRHEA; ADULTS; RISK;
D O I
10.1111/his.14702
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims Patients with inflammatory bowel disease (IBD) are at increased risk for Clostridioides difficile infection, although clinically important infections can be difficult to recognise. C. difficile infection does not produce pseudomembranes when it occurs in IBD patients. These individuals may also be colonised by the organism, in which case diarrhoeal symptoms are not necessarily attributed to C. difficile. We performed this study to determine whether any features distinguished C. difficile-associated colitis from an IBD flare. Methods and results We reviewed the clinical, endoscopic and biopsy findings from 50 patients with established IBD and worsening diarrhoea, including 22 with concurrent positive C. difficile stool toxin polymerase chain reaction (PCR) assays and 28 with negative C. difficile assay results. We found that C. difficile-infected patients had symptoms and endoscopic findings that were indistinguishable from active IBD. Although most biopsy samples from patients with C. difficile infection showed chronic active colitis indistinguishable from IBD, some displayed neutrophilic infiltrates unaccompanied by plasma cell-rich inflammation involving superficial (41%) and crypt (18%) epithelium as well as neutrophilic infiltrates within lamina propria distant from foci of cryptitis (32%). All three of these features were significantly more common among infected than uninfected patients (4, 0 and 4%; P = 0.002, P = 0.03 and P = 0.02, respectively). Conclusions Although colonic biopsies from IBD patients with C. difficile infection usually lack features that aid distinction from colitic flares, some cases show an acute colitis pattern not seen in IBD alone. When identified in biopsies from symptomatic IBD patients, these changes should alert pathologists to the possibility of this clinically important infection.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [21] Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease
    Reasoner S.A.
    Nicholson M.R.
    Current Gastroenterology Reports, 2023, 25 (11) : 316 - 322
  • [22] Budesonide, an anti-inflammatory drug, exacerbate clostridioides difficile colitis in mice
    Lin, Qianyun
    Li, Zitong
    Lu, Lei
    Xu, Hua
    Lou, Eddie
    Chen, Alyssa
    Sun, Dustin
    Zhang, Wuyi
    Zhu, Weishu
    Yee, Eric U.
    Sears, Pamela Suzanne
    Chen, Xinhua
    Kelly, Ciaran P.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [23] Molecular characterization and antibiotic resistance of Clostridioides difficile in patients with inflammatory bowel disease from two hospitals in China
    Lv, Tao
    Zheng, Lisi
    Wu, Tao
    Shen, Ping
    Chen, Yunbo
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 30 : 252 - 258
  • [24] Gut community alterations associated with Clostridioides difficile colonization in hospitalized gastroenterological patients with or without inflammatory bowel disease
    Mahnic, Aleksander
    Pintar, Spela
    Skok, Pavel
    Rupnik, Maja
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [25] Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
    Yu, Si
    Ge, Xiaomeng
    Xu, Hui
    Tan, Bei
    Tian, Bowen
    Shi, Yujie
    Dai, Yimin
    Li, Yue
    Hu, Songnian
    Qian, Jiaming
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [26] Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
    Lam, Angela Y.
    Gutin, Liat S.
    Nguyen, Yume
    Velayos, Fernando S.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (11) : 3111 - 3115
  • [27] Clostridium Difficile and Inflammatory Bowel Disease (Reprinted from Gastroenterology Clinics of North America, vol 38)
    Ananthakrishnan, Ashwin N.
    Issa, Mazen
    Binion, David G.
    MEDICAL CLINICS OF NORTH AMERICA, 2010, 94 (01) : 135 - +
  • [28] Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection
    Allegretti, Jessica R.
    Kelly, Colleen R.
    Grinspan, Ari
    Mullish, Benjamin H.
    Hurtado, Jonathan
    Carrellas, Madeline
    Marcus, Jenna
    Marchesi, Julian R.
    McDonald, Julie A. K.
    Gerardin, Ylaine
    Silverstein, Michael
    Pechlivanis, Alexandros
    Barker, Grace F.
    Blanco, Jesus Miguens
    Alexander, James L.
    Gallagher, Kate, I
    Pettee, Will
    Phelps, Emmalee
    Nemes, Sara
    Sagi, Sashidhar, V
    Bohm, Matthew
    Kassam, Zain
    Fischer, Monika
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (09) : 1371 - 1378
  • [29] Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection
    Solanky, Dipesh
    Pardi, Darrell S.
    Loftus, Edward V., Jr.
    Khanna, Sahil
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (03) : 610 - 619
  • [30] Treatment of an Initial Infection with Clostridium difficile in Patients with Inflammatory Bowel Disease
    Khanna, Reena
    Chande, Nilesh
    Nelson, Richard L.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (10) : 2223 - 2226